Treatment of Adolescent Suicide Attempters (TASA)

New York State Psychiatric Institute6 sites in 1 country120 target enrollmentMarch 2004

ConditionsDepression Suicide, Attempted

Drugsfluoxetine sertraline citalopram escitalopram bupropion mirtazapine venlafaxine lithium

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Depression
Sponsor: New York State Psychiatric Institute
Enrollment: 120
Locations: 6
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.

Detailed Description

Suicide is the third leading cause of death in adolescents and is a major public health problem. Depression is the most common diagnosis for adolescent suicide attempts. Little is known about what treatment is best for these adolescents since they are usually excluded from participation in research studies. Participants in this study will be randomly assigned to receive carefully monitored antidepressant medication with routine support and management, cognitive behavioral therapy (CBT), or a combination of antidepressant medication plus CBT.

Registry

clinicaltrials.gov

Start Date

March 2004

End Date

June 2007

Last Updated

5 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

New York State Psychiatric Institute

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•At least one suicide attempt or interrupted attempt within the past 45 days
•Continuously reside with a primary caretaker (parent, legal guardian, foster parent) for at least 6 months that can provide legal consent